(Q43180502)

15 November 2017

title

Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs (English)

1 reference

15 November 2017

0 references

László Selmeci

1

1 reference

15 November 2017

Leila Seres

2

1 reference

15 November 2017

Mária Székely

3

1 reference

15 November 2017

Pál Soós

4

1 reference

15 November 2017

György Acsády

5

1 reference

15 November 2017

publication date

1 March 2010

1 reference

Clinical Chemistry and Laboratory Medicine

15 November 2017

published in

1 reference

15 November 2017

volume

48

1 reference

15 November 2017

issue

3

1 reference

15 November 2017

page(s)

379-382

1 reference

Fibrinogen is an antioxidant that protects beta-lipoproteins at physiological concentrations in a cell free system

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Fibrinogen is a co-antioxidant that supplements the vitamin E analog trolox in a model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Mapping of a minimal apolipoprotein(a) interaction motif conserved in fibrin(ogen) beta - and gamma -chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Quantification and significance of protein oxidation in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

21 January 2018

Fibrinogen and fibrin.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Circulating markers of inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

Atherosclerosis--an immune disease: The Anitschkov Lecture 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.076

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.076

1 reference

15 November 2017

1 reference